Step 3: NICE Assessment (For NHS Use) If MHRA approval is granted, the medicine may then be assessed by NICE to determine: Cost-effectiveness Eligible patient groups Prescribing criteria Whether the NHS funds it This stage mainly affects NHS availability, but private prescribing decisions may differ depending on the product licence
IGF-1 LR3 We found 4 products available for you
Quantitative proteomic analysis of wheat cultivars with differing drought stress tolerance
Research confirms that strength training maximizes fat loss while retaining muscle
We have very good signals and studies showing a reduction in cardiovascular disease in myocardial infarction, heart failure, preserved ejection fraction, atrial fibrillation
The program includes prescribed dosing, basic usage guidance, and delivery through a partner pharmacy